India to Sri Lanka: Budesonide Export Trade Route
India has recorded 117 verified shipments of Budesonide exported to Sri Lanka, representing a combined trade value of $3.8M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $32.6K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 67% of total export value with 56 shipments worth $2.6M USD. On the buying side, BREATHEFREE LANKA PVT LTD is the largest importer in Sri Lanka with $1.7M USD in purchases. The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , ZYDUS LIFESCIENCES LIMITED — together control 88% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Sri Lanka Budesonide corridor is one of India's established pharmaceutical export routes, with 117 shipments documented worth a combined $3.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 67% of all export value, reflecting the consolidated nature of India's budesonide manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $32.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with budesonide's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 19.8%, placing it at rank #18 among India's top budesonide export destinations globally.
On the import side, key buyers of Indian budesonide in Sri Lanka include BREATHEFREE LANKA PVT LTD, BREATHEFREE LANKA PRIVATE LIMITED, BREATHEFREE LANKA PVT LTD and 8 others. BREATHEFREE LANKA PVT LTD is the single largest importer with 35 shipments valued at $1.7M USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ3
- Primary modeSea freight
- Top portJNPT
Market Position
- Global rank#18
- Annual growth+19.8%
- Demand growth+16.9%
- Regulatory ease82/100
Top 10 Indian Budesonide Exporters to Sri Lanka
Showing top 10 of 10 Indian suppliers exporting Budesonide to Sri Lanka, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $45.6K per shipment | 56 | $2.6M | 66.9% |
| 2 | CIPLA LIMITED Avg $61.9K per shipment | 9 | $557.0K | 14.6% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $16.2K per shipment | 15 | $242.8K | 6.4% |
| 4 | CADILA HEALTHCARE LIMITED Avg $13.0K per shipment | 11 | $142.9K | 3.7% |
| 5 | LUPIN LIMITED Avg $36.4K per shipment | 3 | $109.1K | 2.9% |
| 6 | CADILA HEALTHCARE LTD Avg $5.3K per shipment | 13 | $68.4K | 1.8% |
| 7 | ZYDUS LIFESCIENCES LIMITED Avg $19.1K per shipment | 3 | $57.2K | 1.5% |
| 8 | AXA PARENTERALS LIMITED Avg $11.0K per shipment | 4 | $43.9K | 1.2% |
| 9 | AXA PARENTERALS LIMITED Avg $20.1K per shipment | 2 | $40.2K | 1.1% |
| 10 | HIGGS HEALTHCARE Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting budesonide to Sri Lanka, ranked by total trade value. The listed exporters are: CIPLA LIMITED, CIPLA LIMITED , ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, LUPIN LIMITED, CADILA HEALTHCARE LTD, ZYDUS LIFESCIENCES LIMITED , AXA PARENTERALS LIMITED, AXA PARENTERALS LIMITED , HIGGS HEALTHCARE . CIPLA LIMITED is the dominant supplier with 56 shipments worth $2.6M USD, giving it a 67% market share. The top 3 suppliers together account for 88% of the total trade value on this route.
Top 10 Budesonide Importers in Sri Lanka
Showing top 10 of 11 known buyers in Sri Lanka receiving Budesonide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian budesonide in Sri Lanka include BREATHEFREE LANKA PVT LTD, BREATHEFREE LANKA PRIVATE LIMITED, BREATHEFREE LANKA PVT LTD , SUNSHINE HEALTHCARE LANKA LIMITED, TO, among 11 total buyers. The largest importer is BREATHEFREE LANKA PVT LTD, accounting for $1.7M USD across 35 shipments — representing 46% of all budesonide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BREATHEFREE LANKA PVT LTD | 35 | $1.7M | 45.5% |
| 2 | BREATHEFREE LANKA PRIVATE LIMITED | 21 | $816.6K | 21.4% |
| 3 | BREATHEFREE LANKA PVT LTD | 9 | $557.0K | 14.6% |
| 4 | SUNSHINE HEALTHCARE LANKA LIMITED | 35 | $429.1K | 11.2% |
| 5 | TO | 3 | $109.1K | 2.9% |
| 6 | SUNSHINE HEALTHCARE LANKA LIMITED | 3 | $57.2K | 1.5% |
| 7 | TO THE ORDER OF PEOPLES BANK | 2 | $40.2K | 1.1% |
| 8 | SUNSHINE HEALTHCARE LANKA LTD | 4 | $25.0K | 0.7% |
| 9 | TO THE ORDER OF PEOPLES BANK | 3 | $24.0K | 0.6% |
| 10 | TO THE ORDER OF BANK OF CEYLON | 1 | $19.9K | 0.5% |
Showing top 10 of 11 Budesonide importers in Sri Lanka on this route.
Top 10 Budesonide Formulations Imported by Sri Lanka
Showing top 10 of 70 product formulations shipped on the India to Sri Lanka Budesonide route, ranked by trade value
Sri Lanka imports a wide range of budesonide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — FORACORT 400 INHALER (CFC FREE) (NON ALCOHOLIC) WITH DOSE INDICATOR(FORMOTEROL FUMARATE 6MCG+BUDESONIDE 400MC — accounts for $249.8K USD across 3 shipments. There are 70 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FORACORT 400 INHALER (CFC FREE) (NON ALCOHOLIC) WITH DOSE INDICATOR(FORMOTEROL FUMARATE 6MCG+BUDESONIDE 400MC | 3 | $249.8K | 6.5% |
| 2 | FORACORT 400 DP CAPS FORMOTEROL FUMARATE 6 MCG BUDESONIDE 400 MCG ROTA INV QTY 19754 PACK 10X10S 1975400 NOS | 2 | $206.6K | 5.4% |
| 3 | FORACORT 400 INHALER CFC FREE NON ALCOHOLICWITH DOSE INDICATOR FORMOTEROLFUMARATE 6 MCG+ BUDESONIDE 400MCG | 1 | $189.6K | 5.0% |
| 4 | FORACORT 400 DP CAPS FORMOTEROL FUMARATE 6 MCG BUDESONIDE 400 MCG ROTA INV QTY 13500 PACK 10X10S 1350000 NOS | 2 | $141.2K | 3.7% |
| 5 | FORACORT400 DP CAPS (FORMOTEROL FUMARATE 6MCG+BUDESONIDE 400MCG ROTA) (INV. QTY. 19687 PACK 10X10'S=1968700) | 1 | $132.3K | 3.5% |
| 6 | FORACORT400 DP CAPS (FORMOTEROL FUMARATE 6MCG+BUDESONIDE 400MCG ROTA) ( INV. QTY. 18852 PACK 10 X 10'S = 1885 | 1 | $125.0K | 3.3% |
| 7 | FORACORT400 DP CAPS (FORMOTEROL FUMARATE6MCG+BUDESONIDE 400MCG ROTA) (INV.QTY.19628 PACK 10X10S=1962800 NOS)NOS | 3 | $123.9K | 3.2% |
| 8 | FORACORT400 DP CAPS (FORMOTEROL FUMARATE6MCG+BUDESONIDE 400MCG ROTA) (INV.QTY.19575 PACK 10X10S=1957500 NOS)NOS | 3 | $123.6K | 3.2% |
| 9 | FORACORT 400 INHALER (CFC FREE) (NON ALCOHOLIC) WITH DOSE INDICATOR(FORMOTEROL FUMARATE 6 MCG + BUDESONIDE 40 | 1 | $120.7K | 3.2% |
| 10 | FORACORT400 DP CAPS (FORMOTEROL FUMARATE6MCG+BUDESONIDE 400MCG ROTA) 18727 PACK10 X 10'SNOS | 3 | $118.1K | 3.1% |
Showing top 10 of 70 Budesonide formulations imported by Sri Lanka on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT handles the highest volume with 33 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's budesonide exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 56 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , ZYDUS LIFESCIENCES LIMITED — together account for 88% of total trade value on this route. The average shipment value of $32.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as foracort 400 dp caps formoterol fumarate 6 mcg budesonide 400 mcg rota inv qty 19754 pack 10x10s 1975400 nos and foracort 400 inhaler cfc free non alcoholicwith dose indicator formoterolfumarate 6 mcg+ budesonide 400mcg, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BREATHEFREE LANKA PVT LTD is the largest importer with 35 shipments worth $1.7M USD — representing 46% of all budesonide imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.8M
- Avg. Shipment
- $32.6K
- Suppliers
- 10
- Buyers
- 11
- Transit (Sea)
- ~25 days
- Annual Growth
- +19.8%
Related Analysis
Other Budesonide Routes
Unlock the Full India to Sri Lanka Budesonide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 117 shipments on this route.
Frequently Asked Questions — India to Sri Lanka Budesonide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Budesonide to Sri Lanka?
The leading Indian exporters of Budesonide to Sri Lanka are CIPLA LIMITED, CIPLA LIMITED , ZYDUS LIFESCIENCES LIMITED. CIPLA LIMITED holds the largest market share at approximately 67% of total trade value on this route.
Q What is the total value of Budesonide exports from India to Sri Lanka?
India exports Budesonide to Sri Lanka worth approximately $3.8M USD across 117 recorded shipments. The average value per shipment is $32.6K USD.
Q Which ports does India use to ship Budesonide to Sri Lanka?
The most active port of origin is JNPT with 33 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Sri Lanka for Budesonide?
The average transit time for Budesonide shipments from India to Sri Lanka is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Sri Lanka Budesonide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.8% with demand growth tracking at 16.9%. The route is ranked #18 among India's top Budesonide export destinations globally.
Q How many suppliers are active on the India to Sri Lanka Budesonide route?
There are currently 10 active Indian suppliers exporting Budesonide to Sri Lanka. The market is moderately concentrated with CIPLA LIMITED accounting for 67% of total shipment value.
Q Who are the main importers of Budesonide from India in Sri Lanka?
The leading importers of Indian Budesonide in Sri Lanka include BREATHEFREE LANKA PVT LTD, BREATHEFREE LANKA PRIVATE LIMITED, BREATHEFREE LANKA PVT LTD , SUNSHINE HEALTHCARE LANKA LIMITED, TO. BREATHEFREE LANKA PVT LTD is the largest buyer with 35 shipments worth $1.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Sri Lanka export trade corridor identified from Indian Customs (DGFT) records for Budesonide.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 11 importers in Sri Lanka matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 117 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
117 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists